Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...
StemWave acoustic wave therapy is now available in DuBois, Western Pennsylvania through Mercy Family Health, offering FDA-cleared technology that increases blood circulation and targets nerve damage ...
Please provide your email address to receive an email when new articles are posted on . Multiple diagnostic tools are necessary to assess diabetic peripheral neuropathy in patients. The choice of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results